Has Francis Bain received payments from drug or device companies?

Yes. Drug and device makers reported $4,429 in general payments to Francis Bain across 111 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Francis Bain did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Francis Bain come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Francis Bain

Family Medicine · Goochland, VANPI 1629072608

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,254 and has fallen 52.6% since, to $1,068 in 2021.

$4,429in general payments, 2019–2025

Across 111 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$928
Pfizer$506
Amarin Pharma, Inc.$477
Esperion Therapeutics, Inc.$337
AbbVie$303
Boehringer Ingelheim$283
plus $2K from 14 others

What the payments were for

Food & beverage$4,40399%
Education$261%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	8	$928
Pfizer	16	$506
Amarin Pharma, Inc.	13	$477
Esperion Therapeutics, Inc.	6	$337
AbbVie(2 entities)	9	$303
Boehringer Ingelheim	6	$283
AstraZeneca	18	$282
Lilly USA, LLC	12	$234
Johnson & Johnson	4	$223
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$220
GSK	4	$143
Astellas Pharma US Inc	1	$125
Novo Nordisk	1	$96
Edwards Lifesciences	1	$90
Sanofi-aventis U.S. LLC	1	$85
Kowa Pharmaceuticals America, Inc.	2	$26
Sunovion Pharmaceuticals Inc.	1	$21
Mannkind Corporation	1	$20
Merck	1	$16
Novartis	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,429 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia →

Other family medicine in Goochland

Oluwaronke AwosikaFort Gregg Adams$397K
Monique MatuskowitzNorfolk$110K
Paul StairsRichmond$105K
Edwin RobinsonRichmond$83K
Benjamin PhilpottRocky Mount$64K
John MolaiyArlington$64K
Catherine VarneyZion Crossroads$47K
Jordan TranWinchester$42K
John ClayColonial Heights$40K
Thomas RobesonNewport News$34K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →